Nancy Miller-Rich - 03 May 2021 Form 4 Insider Report for Aldeyra Therapeutics, Inc. (ALDX)

Role
Director
Signature
/s/ Nancy Miller-Rich
Issuer symbol
ALDX
Transactions as of
03 May 2021
Net transactions value
+$10,447
Form type
4
Filing time
21 Oct 2024, 20:22:37 UTC
Next filing
13 May 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALDX Common Stock Purchase $5,291 +413 $12.81 413 03 May 2021 Direct F1
transaction ALDX Common Stock Purchase $5,156 +509 +123% $10.13 922 12 Apr 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchases reported herein were executed under the trading discretion of an investment advisor in a managed account, without any instruction from or knowledge of the Reporting Person. The Reporting Person only recently become aware of these transactions.